Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Go back to Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Trevi Therapeutics (TRVI) Misses Q1 EPS by 2c

May 7, 2024 4:23 PM EDT

Trevi Therapeutics (NASDAQ: TRVI) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.

... More